Syneos Health (NASDAQ: SYNH)
Some price data may be temporarily unavailable.
Syneos Health Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Syneos Health Company Info
Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC.
News & Analysis
Will COVID-19 Derail New Drugs?
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
Is Syneos Health Stock a Buy?
The company's revenue has more than doubled in just a few years.
4 Healthcare Services Companies to Own for the Future
Many investors aren’t aware of the vital roles contract research organizations fulfill for pharmaceutical and biotech companies -- or of the billions they make each year for their services.
3 Under-the-Radar Healthcare Stocks With Great Growth Potential
These winning stocks don't make many headlines, but are quietly delivering strong revenue and earnings growth.
Here's Why Syneos Health Plummeted Today
The biopharmaceutical solutions company is under investigation by the SEC.
Why Contract Research Organizations Can Be Money-Making Machines for Investors
Find out how CROs profit from the biotech boom no matter what happens in the clinic.
Valuation
Earnings Transcripts
Syneos Health, inc (SYNH) Q3 2021 Earnings Call Transcript
SYNH earnings call for the period ending September 30, 2021.
Syneos Health, inc (SYNH) Q2 2021 Earnings Call Transcript
SYNH earnings call for the period ending June 30, 2021.
Syneos Health, Inc. (SYNH) Q1 2021 Earnings Call Transcript
SYNH earnings call for the period ending April 29, 2021.
Syneos Health, Inc. (SYNH) Q4 2020 Earnings Call Transcript
SYNH earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.